Department of Immunology, University of Freiburg, 79104 Freiburg, Germany.
German Cancer Consortium (DKTK), DKFZ, 69120 Heidelberg, Germany.
Int J Mol Sci. 2021 Feb 11;22(4):1808. doi: 10.3390/ijms22041808.
Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, with only limited treatment options available. Recently, cancer stem cells (CSCs) have emerged as the potential drivers of tumor progression due to their ability to both self-renew and give rise to differentiated progeny. The CSC state has been linked to the process of epithelial-mesenchymal transition (EMT) and to the highly flexible state of epithelial-mesenchymal plasticity (EMP). We aimed to establish primary breast cancer stem cell (BCSC) cultures isolated from TNBC specimens. These cells grow as tumor spheres under anchorage-independent culture conditions in vitro and reliably form tumors in mice when transplanted in limiting dilutions in vivo. The BCSC xenograft tumors phenocopy the original patient tumor in architecture and gene expression. Analysis of an EMT-related marker profile revealed the concomitant expression of epithelial and mesenchymal markers suggesting an EMP state for BCSCs of TNBC. Furthermore, BCSCs were susceptible to stimulation with the EMT inducer TGF-β1, resulting in upregulation of mesenchymal genes and enhanced migratory abilities. Overall, primary BCSC cultures are a promising model close to the patient that can be used both in vitro and in vivo to address questions of BCSC biology and evaluate new treatment options for TNBC.
三阴性乳腺癌(TNBC)是乳腺癌中侵袭性最强的亚型之一,目前仅有有限的治疗选择。最近,癌症干细胞(CSCs)因其自我更新和产生分化后代的能力,被认为是肿瘤进展的潜在驱动因素。CSC 状态与上皮-间充质转化(EMT)过程以及上皮-间充质可塑性(EMP)的高度灵活状态有关。我们旨在建立从 TNBC 标本中分离的原发性乳腺癌干细胞(BCSC)培养物。这些细胞在体外无锚定培养条件下作为肿瘤球体生长,并在体内进行有限稀释移植时可靠地在小鼠中形成肿瘤。BCSC 异种移植肿瘤在结构和基因表达上与原始患者肿瘤相似。对 EMT 相关标志物谱的分析显示上皮和间充质标志物的同时表达,提示 TNBC 的 BCSC 处于 EMP 状态。此外,BCSCs 对 EMT 诱导剂 TGF-β1 的刺激敏感,导致间充质基因上调和增强的迁移能力。总之,原发性 BCSC 培养物是一种接近患者的有前途的模型,可用于体外和体内研究 BCSC 生物学,并评估 TNBC 的新治疗选择。